SCHEMBL6399579

SCHEMBL6399579

CCCC(C)OCC(O)COc1ccc(-c2ncnc(-c3ccccc3)n2)c(O)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.38
HTT P42858 1/20 0.38
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
MAPK10 P53779 1/20 0.37
CDK4 P11802 1/20 0.37
ADRB2 P07550 3/20 0.35
ADRB1 P08588 2/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35
RAD52 P43351 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ADRB3 P13945 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
NCOA1 Q15788 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29353912 0.90 MAPT (0.38) MAPTHTTLMNAGAAMAPK10
SCHEMBL769388 0.90 MAPT (0.38) MAPTHTTLMNAGAAMAPK10
SCHEMBL21752509 0.84 ADRB2 (0.40) MAPTHTTLMNACDK4ADRB2
SCHEMBL14370143 0.84 ADRB2 (0.40) MAPTLMNAADRB2ADRB1MEN1
SCHEMBL7896079 0.81 NR2E1 (0.43) MAPTLMNAGAAMAPK10ADRB2
SCHEMBL3833773 0.80 LMNA (0.40) MAPTHTTLMNAMAPK10CDK4
SCHEMBL18979221 0.79 LMNA (0.40) MAPTLMNAGAAMAPK10CNR1
SCHEMBL6450928 0.79 PLA2G4B (0.40) MAPTHTTLMNAGAAMAPK10
SCHEMBL787012 0.79 ADRB2 (0.44) MAPTLMNAADRB2ADRB1MEN1
SCHEMBL29356358 0.79 ADRB2 (0.44) MAPTLMNAADRB2ADRB1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065166-A1 Substituted pyrimidines BAYER CROPSCIENCE AG (DE) 2005-03-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065166-A1 Substituted pyrimidines DPYD, DHFR, TYMP MAPT 4240/4885HTT 2216/4885LMNA 4169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.